These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18187871)

  • 1. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
    Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
    Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease.
    Shimizu K; Kumita S; Kitamura Y; Nagahama M; Kitagawa W; Akasu H; Oshina T; Kumasaki T; Tanaka S
    J Am Coll Surg; 2002 Jan; 194(1):14-22. PubMed ID: 11800336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
    Lin YS; Lin JD; Hsu CC; Yu MC
    J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
    World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid.
    Uyttersprot N; Pelgrims N; Carrasco N; Gervy C; Maenhaut C; Dumont JE; Miot F
    Mol Cell Endocrinol; 1997 Aug; 131(2):195-203. PubMed ID: 9296378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
    Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Fukata S; Tamai H; Miyauci A; Sugawara M
    Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y; Matoba N; Miura S; Sakai N; Taira Y
    World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
    Wilkin TJ; Gunn A; Isles TE; Crooks J; Beck JS
    Lancet; 1979 Jul; 2(8133):63-6. PubMed ID: 87965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
    Nonchev BI; Terzieva DD; Dimov RS; Mateva NG; Tsvetkova TZ; Dimitrakov DY
    Folia Med (Plovdiv); 2005; 47(3-4):40-5. PubMed ID: 16761393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of Graves' disease: subtotal thyroidectomy might still be the preferred option.
    Lepner U; Seire I; Palmiste V; Kirsimägi U
    Medicina (Kaunas); 2008; 44(1):22-6. PubMed ID: 18277085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy.
    Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Endocr J; 2012; 59(12):1115-20. PubMed ID: 22971989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and tissue distribution of the human sodium iodide symporter gene.
    Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal TSH Prior to Surgery in Children with Graves' Disease Predicts Abnormal TSH Following Thyroidectomy.
    Hazkani I; Stein E; Edwards E; Maddalozzo J; Johnston D; Samis J; Josefson J; Rastatter J
    Laryngoscope; 2023 Sep; 133(9):2402-2406. PubMed ID: 36370147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.
    Witte J; Goretzki PE; Dotzenrath C; Simon D; Felis P; Neubauer M; Röher HD
    World J Surg; 2000 Nov; 24(11):1303-11. PubMed ID: 11038198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
    Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
    Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of Graves' disease -10-year prospective trial at a single institution.
    Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ito K
    Endocr J; 2008 Mar; 55(1):161-7. PubMed ID: 18250542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.